封面
市场调查报告书
商品编码
1664002

特种酵素市场规模、份额和成长分析(按来源、产品类型、应用和地区)- 产业预测 2025-2032

Specialty Enzymes Market Size, Share, and Growth Analysis, By Source (Plants, Animals), By Product Type (Carbohydrases, Proteases), By Application, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 189 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计 2023 年全球特种酵素市场规模将达到 61.6 亿美元,并从 2024 年的 66.1 亿美元成长到 2032 年的 116.1 亿美元,预测期内(2025-2032 年)的复合年增长率为 7.3%。

受製药业需求不断增长的推动,特种酶市场预计将经历强劲增长。酵素在促进药物发现、开发和生产过程中发挥着至关重要的作用。从先导化合物优化到治疗目标检验,酵素在药物开发的许多阶段都至关重要。透过促进生化途径的研究,酵素可帮助研究人员确定潜在的治疗目标并评估新药物的功效。在药物中间体和类似物的合成中使用酵素简化了开发平臺。此外,特种酵素在生技药品和活性药物成分 (API) 的製造中至关重要,它可作为生物催化剂来提高效率和选择性、降低成本、提高产量并减少环境影响,从而极大地影响药物配方。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 次要和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024 年)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 专利分析

特种酵素市场规模(按来源和复合年增长率) (2025-2032)

  • 市场概况
  • 植物
  • 动物
  • 微生物

特种酵素市场规模(按产品类型和复合年增长率) (2025-2032)

  • 市场概况
  • 碳水化合物分解酶
  • 蛋白酶
  • 脂肪酶
  • 聚合酵素和核酸酶
  • 其他的

特种酵素市场规模(依应用划分)及复合年增长率(2025-2032)

  • 市场概况
  • 食品和饮料
  • 药品
  • 动物营养
  • 生物技术
  • 诊断
  • 其他的

特种酵素市场规模(依地区划分)及复合年增长率(2025-2032)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲国家
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前 5 家公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采用的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024 年)
  • 主要企业简介
    • 公司详细信息
    • 产品系列分析
    • 公司分部份额分析
    • 收益与前一年同期比较对比(2022-2024 年)

主要企业简介

  • Novozymes A/S(Denmark)
  • DuPont de Nemours, Inc.(USA)
  • DSM(Netherlands)
  • BASF SE(Germany)
  • Advanced Enzyme Technologies Ltd.(India)
  • Amano Enzyme Inc.(Japan)
  • Codexis, Inc.(USA)
  • Sanofi(France)
  • Roche Holding AG(Switzerland)
  • Thermo Fisher Scientific Inc.(USA)
  • Biocatalysts Ltd.(UK)
  • Merck KGaA(Germany)
  • Kerry Group plc(Ireland)
  • Specialty Enzymes & Probiotics(USA)
  • AST Enzymes(USA)
  • Nagase & Co., Ltd.(Japan)
  • Dyadic International, Inc.(USA)
  • AB Enzymes GmbH(Germany)
  • Enzyme Development Corporation(USA)

结论和建议

简介目录
Product Code: SQMIG35H2329

Global Specialty Enzymes Market size was valued at USD 6.16 billion in 2023 and is poised to grow from USD 6.61 billion in 2024 to USD 11.61 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The specialty enzymes market is poised for robust growth, driven by the increasing demand from the pharmaceutical sector. Enzymes play a pivotal role in enhancing drug discovery, development, and production processes. They are integral to various phases of drug development, from optimizing lead compounds to validating therapeutic targets. By facilitating the study of biochemical pathways, enzymes help researchers identify potential therapeutic targets and evaluate the effectiveness of new substances. Their use in synthesizing drug intermediates and analogues streamlines the development pipeline. Moreover, specialty enzymes are crucial in the manufacturing of biologics and active pharmaceutical ingredients (APIs), acting as biocatalysts that enhance efficiency and selectivity, reduce costs, improve yields, and lower environmental impact, significantly influencing pharmaceutical formulations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Specialty Enzymes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Specialty Enzymes Market Segments Analysis

Global Specialty Enzymes Market is segmented by Source, Product Type, Application and region. Based on Source, the market is segmented into Plants, Animals and Microorganisms. Based on Product Type, the market is segmented into Carbohydrases, Proteases, Lipases, Polymerases & Nucleases and Others. Based on Application, the market is segmented into Food & Beverages, Pharmaceuticals, Animal Nutrition, Biotechnology, Diagnostics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Specialty Enzymes Market

The increasing global emphasis on sustainability is a significant driver of growth in the specialty enzymes market. As both consumers and businesses prioritize eco-friendly and biodegradable options, sectors like food, textiles, and cleaning are experiencing heightened demand. This shift toward cleaner and more sustainable solutions propels the adoption of enzymes in various applications. Companies are actively seeking innovative, environmentally conscious alternatives, which further amplifies the market's expansion. The integration of specialty enzymes in these industries not only meets consumer expectations for sustainability but also aligns with broader environmental goals, ultimately fostering increased market activity and development in this sector.

Restraints in the Global Specialty Enzymes Market

Limited awareness of the advantages and versatile applications of specialty enzymes in certain regions and industries serves as a significant constraint on the Global Specialty Enzymes market. A considerable number of companies continue to rely on conventional chemical processes, making the transition to enzyme-based solutions challenging. This shift necessitates substantial education and investment, causing slower adoption rates, particularly in emerging markets. Consequently, the lack of understanding and readiness to embrace innovative enzyme technologies hampers market growth and stifles the potential benefits that these advanced solutions could offer to various sectors. Thus, this lack of awareness remains a considerable barrier.

Market Trends of the Global Specialty Enzymes Market

The Global Specialty Enzymes market is witnessing a significant trend towards the adoption of eco-friendly and biodegradable enzyme solutions, driven by increasing environmental awareness among consumers and businesses alike. Industries such as food and beverage, textiles, and cleaning are prioritizing sustainability, opting for specialty enzymes that minimize ecological footprints. This shift not only caters to consumer demand for greener products but also aligns with regulatory pressures for reduced environmental impact. Consequently, manufacturers are focusing on innovation and the development of cleaner, more efficient enzymatic processes, positioning themselves strategically to meet the rising emphasis on sustainability, thereby fueling market growth.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Patent Analysis

Global Specialty Enzymes Market Size by Source & CAGR (2025-2032)

  • Market Overview
  • Plants
  • Animals
  • Microorganisms

Global Specialty Enzymes Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Carbohydrases
  • Proteases
  • Lipases
  • Polymerases & Nucleases
  • Others

Global Specialty Enzymes Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Food & Beverages
  • Pharmaceuticals
  • Animal Nutrition
  • Biotechnology
  • Diagnostics
  • Others

Global Specialty Enzymes Market Size & CAGR (2025-2032)

  • North America (Source, Product Type, Application)
    • US
    • Canada
  • Europe (Source, Product Type, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Source, Product Type, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Source, Product Type, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Source, Product Type, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Novozymes A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DuPont de Nemours, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DSM (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BASF SE (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced Enzyme Technologies Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amano Enzyme Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Codexis, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biocatalysts Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kerry Group plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Specialty Enzymes & Probiotics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AST Enzymes (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nagase & Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dyadic International, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AB Enzymes GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Enzyme Development Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations